Schedule 13G ownership disclosure

ArriVent Biopharma Inc

Common Stock · CUSIP: 04272N102

Event date: 2025-09-30

Filing-level shares
2,007,338
Percent of class
4.9%
  • BlackRock, Inc.

    Shares: 2,007,338 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002012383-25-002500
Form type
SCHEDULE 13G/A
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Oct 17, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub